Impact of treating iron deficiency, diagnosed according to hepcidin quantification, on outcomes after a prolonged ICU stay compared to standard care: a multicenter, randomized, single-blinded trial

BACKGROUND: Anemia is a significant problem in patients on ICU. Its commonest cause, iron deficiency (ID), is difficult to diagnose in the context of inflammation. Hepcidin is a new marker of ID. We aimed to assess whether hepcidin levels would accurately guide treatment of ID in critically ill anem...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Crit Care
Main Authors: Lasocki, Sigismond, Asfar, Pierre, Jaber, Samir, Ferrandiere, Martine, Kerforne, Thomas, Asehnoune, Karim, Montravers, Philippe, Seguin, Philippe, Peoc’h, Katell, Gergaud, Soizic, Nagot, Nicolas, Lefebvre, Thibaud, Lehmann, Sylvain
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2021
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7885380/
https://ncbi.nlm.nih.gov/pubmed/33588893
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13054-020-03430-3
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados